A study published in ESMO Open evaluated outcomes of second-line chemotherapy combinations for patients with metastatic pancreatic cancer who had failed on first-line treatments.
Second-Line Therapy Outcomes in Metastatic Pancreatic Cancer
Jordan Litaker2021-03-16T11:01:05+00:00March 16th, 2021|Pancreatic Cancer Newsletter|Comments Off on Second-Line Therapy Outcomes in Metastatic Pancreatic Cancer